IPEC likes what China's doing with excipients; Ranbaxy reports surprise loss;

> A 140% surge in North American sales, driven by its generic Lipitor, was not enough to keep Ranbaxy Laboratories from reporting a quarterly loss. Story

> Uganda has banned 67 drugs from Indian maker Flamingo, claiming that they are substandard. Story

> CVS Caremark ($CVS) realized an 18.4% earnings jump in the last quarter, having grabbed business during the Walgreen ($WAG), Express Scripts ($ESRX) fight. Story

> New guidelines from China's State Food and Drug Administration (SFDA) for excipients has impressed The International Pharmaceutical Excipients Council (IPEC) Americas, which says they are consistent with its own guidelines. Story

And Finally... University of Central Florida scientists think they have stumbled upon a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.